Allurion

While in current times weight loss is no longer driven by outdated aesthetic considerations, it's still true that diet and exercise alone do not always seem to work and the available alternatives require invasive surgery or endoscopy. This creates a space in the market which Allurion occupies with its combination of non-surgical gastric balloon to physically regulate hunger, app-based health tracker, and personalized nutrition and exercise plan. In over a decade it has treated over 100,000 patients in 60 countries.

Allurion has secured large amounts of investment, pushing its expansion into India and Brazil, and allowing it to hire highly qualified individuals to its board to speed its applications for approval in new markets as well as develop the product. It has also been researching AI-based solutions to weight loss that could be included as part of its Virtual Care Suite, in tandem with its physical products, adding yet another dimension to Allurion's strong offering.